Sugammadex and anaphylaxis in the operating theater

Revista Espanola de Anestesiologia y Reanimacion

Volumn 61, Issue 5, 2014, Pages 239-245

  Baldo, B A ^a   McDonnell, N J ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANE DERIVATIVE; EPINEPHRINE; GAMMA CYCLODEXTRIN DERIVATIVE; IMMUNOGLOBULIN E; ROCURONIUM; SUGAMMADEX;

ADOLESCENT; ADULT; AGED; ANAPHYLAXIS; ANTAGONISTS AND INHIBITORS; CAUSALITY; CHEMICALLY INDUCED; CHILD; DELAYED EMERGENCE FROM ANESTHESIA; DRUG HYPERSENSITIVITY; DRUG SURVEILLANCE PROGRAM; FEMALE; HUMAN; IMMUNOLOGY; INTRAOPERATIVE COMPLICATIONS; MALE; MIDDLE AGED; SKIN TEST; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AGED, 80 AND OVER; ANAPHYLAXIS; ANDROSTANOLS; CAUSALITY; CHILD; DELAYED EMERGENCE FROM ANESTHESIA; DRUG HYPERSENSITIVITY; EPINEPHRINE; FEMALE; GAMMA-CYCLODEXTRINS; HUMANS; IMMUNOGLOBULIN E; INTRAOPERATIVE COMPLICATIONS; MALE; MIDDLE AGED; SKIN TESTS; YOUNG ADULT;

EID: 84898432541     PISSN: 00349356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redar.2014.02.005     Document Type: Article

References (51)

1. Adam J.M., Bennett D.J., Bom A., Clark J.K., Feilden H., Hutchinson E.J., et al. Cyclodextrin-derived host molecules as reversal agents for the neuromuscular blocker rocuronium bromide: synthesis and structure-activity relationships. J Med Chem 2002, 45:1806-1816.
2. Epemolu O., Bom A., Hope F., Mason R. Reversal of neuromuscular blockade and simultaneous increase in plasma rocuronium concentration after the intravenous infusion of the novel reversal agent Org 25969. Anesthesiology 2003, 99:632-637.
3. de Kam P.J., van Kuijk J., Prohn M., Thomsen T., Peeters P. Effects of sugammadex doses up to 32mg/kg alone or in combination with rocuronium or vecuronium on QTc prolongation: a thorough QTc study. Clin Drug Investig 2010, 30:599-611.
4. Peeters P.A., van den Heuvel M.W., van Heumen E., Passier P.C., Smeets J.M., van Iersel T., et al. Safety, tolerability and pharmacokinetics of sugammadex using single high doses (up to 96mg/kg) in healthy adult subjects: a randomized, double-blind, crossover, placebo-controlled, single-centre study. Clin Drug Investig 2010, 30:867-874.
5. Schaller S.J., Fink H. Sugammadex as a reversal agent for neuromuscular block: an evidence-based review. Core Evid 2013, 8:57-67.
6. Baldo B.A., Pham N.H. Drug allergy. Clinical aspects, diagnosis, mechanisms, structure-activity relationships 2013, Springer, New York.
7. Coombs R.R.A., Gell P.G.H. Classification of allergic reactions responsible for clinical hypersensitivity and disease. Clinical aspects of immunology 1975, 761-781. Blackwell, Oxford. P.G.H. Gell, R.R.A. Coombs, P.J. Lachmann (Eds.).
8. Baldo B.A., Pham N.H. Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch. Cancer Metastasis Rev 2013, 32:723-761.
9. Naguib M., Brull S.J. Sugammadex: a novel selective relaxant binding agent. Expert Rev Clin Pharmacol 2009, 2:37-53.
10. Menéndez-Ozcoidi L., Ortiz-Gómez J.R., Olaguibel-Ribero J.M., Salvador-Bravo M.J. Allergy to low dose sugammadex. Anaesthesia 2011, 66:217-219.
11. Motoyama Y., Izuta S., Maekawa N., Chuma R. A case of anaphylactic reaction caused by sugammadex. Masui 2012, 61:746-748. [in Japanese].
12. Soria A., Motamed C., Gaouar H., Chemam S., Amsler E., Francès C. Severe reaction following sugammadex injection: hypersensitivity?. J Investig Allergol Clin Immunol 2012, 22:382.
13. Godai K., Hasegawa-Moriyama M., Kuniyoshi T., Kakoi T., Ikoma K., Isowaki S., et al. Three cases of suspected sugammadex-induced hypersensitivity reactions. Br J Anaesth 2012, 109:216-218.
14. Asahi Y., Omichi S., Adachi S., Kagamiuchi H., Kotani J. Hypersensitivity reaction probably induced by sugammadex. Acta Anesthesiol Taiwan 2012, 50:183-184.
15. Ohshita N., Tsutsumi Y.M., Kasai A., Soga T., Kanamura T., Katayama T., et al. Two cases of anaphylactoid reaction after administration of sugammadex. Jpn J Anesthesiol 2012, 61:1261-1264. [in Japanese].
16. Tokuwaka J., Takahashi S., Tanaka M. Anaphylaxis after sugammadex administration. Can J Anaesth 2013, 60:733-734.
17. Mimaru K., Gotoh K., Fujiwara K., Nakamura A., Nishimura A., Iijima T. A case of anaphylaxis associated with sugammadex administered in a pediatric oral surgery case. J Jpn Dental Soc Anesthesiol 2013, 41:199-200. [in Japanese].
18. Jeyadoss J., Kuruppu P., Nanjappa N., Van Wijk R.M. Sugammadex hypersensitivity - a case of anaphylaxis. Anaesth Intensive Care 2014, 42:89-92.
19. Sadlier P.H.M., Russell T., Clarke R.C., Maycock E., Platt P.R. Intraoperative anaphylaxis to sugammadex and a protocol for intradermal skin testing. Anaesth Intensive Care 2014, 42:93-96.
20. Hasegawa K., Kinoshita M., Asahi T. Difficult ventilation after sugammadex administration: a case report. Masui 2012, 61:749-751. [in Japanese].
21. Kokki M., Ali M., Turunen M., Kokki H. Suspected unexpected adverse effect of sugammadex: hypotension. Eur J Clin Pharmacol 2012, 68:899-900.
22. Brockow K., Garvey L.H., Aberer W., Atanaskovic-Markovic M., Barbaud A., Bilo M.B., et al. Skin test concentrations for systemically administered drugs - an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy 2013, 68:702-712.
23. Aberer W., Bircher A., Romano A., Blanca M., Campi P., Fernandez J., et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 2003, 58:854-863.
24. Axon A.D., Hunter J.M. Anaphylaxis and anaesthesia - all clear now?. Br J Anaesth 2004, 93:501-504.
25. Jones P.M., Turkstra T.P. Mitigation of rocuronium-induced anaphylaxis by sugammadex: the great unknown. Anaesthesia 2010, 65:89-90.
26. Pedersen N.A., Findsen L., Olsen K.S. Should sugammadex be used for the treatment of anaphylaxis induced by rocuronium?. American Society of Anesthesiologists 2010 Meeting Abstracts 2010, [Neuromuscular transmission abstract number A539].
27. McDonnell N.J., Pavy T.J.G., Green L.K., Platt P.R. Sugammadex in the management of rocuronium-induced anaphylaxis. Br J Anaesth 2011, 106:199-201.
28. Funnell A.E., Griffiths J., Hodzovic I. A further case of rocuronium-induced anaphylaxis treated with sugammadex. Br J Anaesth 2011, 107:275-276.
29. Kawano T., Tamura T., Hamaguchi M., Yatabe T., Yamashita K., Yokoyama M. Successful management of rocuronium-induced anaphylactic reactions with sugammadex: a case report. J Clin Anesth 2012, 24:62-64.
30. Raft J., Leclercq M., Longrois D., Meistelman C. Récupération hémodynamique et ventilatoire rapide après injection de sugammadex lors d'un choc anaphylactique au rocuronium, réfractaire au traitement conventionnel. Ann Fr d'Anesth Reanim 2012, 31:158-161.
31. Motamed C., Baguenard P., Bourgain J.L. Possible mitigation of rocuronium-induced anaphylaxis after administration of sugammadex. J Anaesth Clin Pharmacol 2012, 28:127-128.
32. Barbosa F.T., du Cunha R.M. Case of anaphylaxis induced by rocuronium treated with sugammadex. Rev Bras Anestesiol 2012, 62:538-542.
33. Badaoui R., Popov I., Dupont H. Un nouveau cas de choc anaphylactique induit par le rocuronium améioré par le sugammadex. Can J Anaesth 2012, 59:909-910.
34. Barthel F., Stojeba N., Lyons G., Biermann C., Diemunsch P. Sugammadex in rocuronium anaphylaxis: dose matters. Br J Anaesth 2012, 109:646-647.
35. Stensby E.K., Soevik S., Loewhagen B., Dahl V. The successful reversal of a fulminant anaphylactic reaction to rocuronium with sugammadex in an 11 year old boy: a case report. Acta Anaesthesiol Scand 2013, 57(Suppl. 120):15.
36. Ishikawa T., Kawanoue N., Minami E., Iwasaki E., Ishii M., Kobayashi H., et al. A case of rocuronium-induced anaphylactic shock successfully treated with sugammadex. Masui 2013, 62:1320-1322. [in Japanese].
37. Baldo B.A., McDonnell N.J., Pham N.H. The cyclodextrin sugammadex and anaphylaxis to rocuronium: is rocuronium still potentially allergenic in the inclusion complex form?. Mini Rev Med Chem 2012, 12:701-712.
38. Baldo B.A., McDonnell N.J., Pham N.H. Drug-specific cyclodextrins with emphasis on sugammadex, the neuromuscular blocker rocuronium and perioperative anaphylaxis: implications for drug allergy. Clin Exp Allergy 2011, 41:1663-1678.
39. Kaliner M., Austen K.F. Immunologic release of chemical mediators from human tissues. Annu Rev Pharmacol 1975, 15:177-189.
40. Ogawa Y., Grant J.A. Mediators of anaphylaxis. Immunol Allergy Clin N Am 2007, 27:249-260.
41. Gould H.J., Sutton B.J., Beavil A.J., Beavil R.L., McCloskey N., Coker H.A., et al. The biology of IgE and the basis of allergic disease. Annu Rev Immunol 2003, 21:579-628.
42. Baldo B.A. Response to: Jones PM, Turkstra TP. Mitigation of rocuronium-induced anaphylaxis by sugammadex: the great unknown. Anaesthesia 2010, 65:89-90. Available from: www.respond2articles.com/ANA/forums/1009/ShowThread.aspx.
43. Kim K.-E., Rosenberg A., Roberts S., Blumenthal M.N. The affinity of allergen specific IgE and the competition between IgE and IgG for the allergen in Amb a V sensitive individuals. Mol Immunol 1996, 33:873-880.
44. Hantusch B., Scholl I., Harwanegg C., Krieger S., Becker W.-M., Spitzauer S., et al. Affinity determinations of purified IgE and IgG antibodies against the major pollen allergen Phl p 5a and Bet v 1a: discrepancy between IgE and IgG binding strength. Immunol Lett 2005, 97:81-89.
45. Baldo B.A., Fisher M.M., Pham N.H. On the origin and specificity of antibodies to neuromuscular blocking (muscle relaxant) drugs: as immunochemical perspective. Clin Exp Allergy 2009, 39:325-344.
46. Wordsworth H.I., Raja Y., Harrison S. Sugammadex and rocuronium-induced anaphylaxis. Br J Anaesth 2011, 106:911-912.
47. Clarke R.C., Sadlier P.H.M., Platt P.R. The role of sugammadex in the development and modification of an allergic response to rocuronium: evidence from a cutaneous model. Anaesthesia 2012, 67:266-273.
48. Leysen J., Bridts C.H., De Clerck L.S., Ebo D.G. Rocuronium-induced anaphylaxis is probably not mitigated by sugammadex: evidence from an in vitro experiment. Anaesthesia 2011, 66:526-527.
49. Olsson P., Hammarlund A., Pipkorn U. Wheal-and-flare reactions induced by allergen and histamine: evaluation of blood flow with laser Doppler flowmetry. J Allergy Clin Immunol 1988, 82:291-296.
50. Petersen L.J., Mosbech H., Skov P.S. Allergen-induced histamine release in intact human skin in vivo assessed by skin microdialysis technique: characterization of factors influencing histamine releasability. J Allergy Clin Immunol 1996, 97:672-679.
51. Clough G. Experimental models of skin inflammation. Clin Exp Allergy 1999, 29(Suppl. 3):105-108.